Research Article| Volume 126, ISSUE 2, P183-189, May 23, 2008

Association of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina



      Angiographically visible complex lesions which are associated with plaque vulnerability have been shown to correlate strongly with clinical severity of unstable angina (UA). By activating different immune/inflammatory cells or directly acting on the vessel wall leptin has been shown to play a potential role in the development of acute coronary syndrome. However, the relationship between leptin and simple or complex lesion morphology in UA has not been investigated. Therefore, we designed this study to determine the association between plasma leptin level and simple or complex lesions in patients with UA and to see any correlation between leptin and other inflammatory markers in these patients.


      Plasma concentrations of leptin, interleukin (IL)-6, IL-10 and high-sensitivity C-Reactive Protein (hsCRP) were analyzed in 47 patients with UA. These patients were also angiographically studied and divided into two groups: simple lesion (n=18) and complex lesion (n=29) based on the coronary plaque morphology. We further compared them with 20 control subjects having no evidence of coronary artery diseases.


      Plasma leptin concentrations were higher in patients having complex lesions compared to those having simple lesions as well as normal controls. Similarly IL-6 and hsCRP were also higher in complex lesion group compared to simple lesion group and controls, and leptin was positively correlated with IL-6 and hsCRP. Concentrations of IL-10 were lower in simple and complex lesion groups compared to the controls and leptin was negatively correlated with IL-10, but no significant difference between simple and complex lesions was found. Furthermore, leptin was found to be an independent predictor for the complex lesion morphology in UA patients.


      These findings suggested that angiographically visible complex lesions are associated with increased concentrations of leptin, and thus leptin can be a useful biomarker for risk stratification in UA.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cao R.
        • Brakenhielm E.
        • Wahlestedt C.
        • Thyberg J.
        • Cao Y.
        Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF.
        Proc Natl Acad Sci U S A. 2001; 98: 6390-6395
        • Oda A.
        • Taniguchi T.
        • Yokoyama M.
        Leptin stimulates rat aortic smooth muscle cell proliferation and migration.
        Kobe J Med Sci. 2001; 47: 141-150
        • Bouloumie A.
        • Marumo T.
        • Lafontan M.
        • Busse R.
        Leptin induces oxidative stress in human endothelial cells.
        FASEB J. 1999; 13: 1231-1238
        • Singhal A.
        • Farooqi I.S.
        • Cole T.J.
        • et al.
        Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?.
        Circulation. 2002; 106: 1919-1924
        • La Cava A.
        • Matarese G.
        The weight of leptin in immunity.
        Nat Rev Immunol. 2004; 4: 371-379
        • Sanchez-Margalet V.
        • Martin-Romero C.
        • Santos-Alvarez J.
        • Goberna R.
        • Najib S.
        • Gonzalez-Yanes C.
        Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action.
        Clin Exp Immunol. 2003; 133: 11-19
        • Martin R.C.
        • Santos A.J.
        • Goberna R.
        • Sanchez M.V.
        Human leptin enhances activation and proliferation of human circulating T lymphocytes.
        Cell Immunol. 2000; 199: 15-24
        • Lord G.M.
        • Matarese G.
        • Howard J.K.
        • Baker R.J.
        • Bloom S.R.
        • Lechler R.I.
        Leptin modulates the T-cell immune response and reverses starvation induced immunosuppression.
        Nature. 1998; 394: 897-901
        • Ambrose J.A.
        • Winters S.L.
        • Arora R.R.
        • et al.
        Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction.
        J Am Coll Cardiol. 1985; 6: 1233-1238
        • Fuster V.
        • Badimon L.
        • Badimon J.J.
        • Chesebro J.H.
        The pathogenesis of coronary artery disease and the acute coronary syndromes.
        N Engl J Med. 1992; 326: 242-250
        • Meuwissen M.
        • van der Wal A.C.
        • Koch K.T.
        • et al.
        Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation.
        Am J Med. 2003; 114: 521-527
        • Ojio S.
        • Takatsu H.
        • Tanaka T.
        • et al.
        Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction.
        Circulation. 2000; 102: 2063-2069
        • Williams A.E.
        • Freeman M.R.
        • Chisholm R.J.
        • Patt N.L.
        • Armstrong P.W.
        Angiographic morphology in unstable angina pectoris.
        Am J Cardiol. 1988; 62: 1024-1027
        • Bugiardini R.
        • Pozzati A.
        • Borghi A.
        • et al.
        Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome.
        Am J Cardiol. 1991; 67: 460-464
        • Mehran R.
        • Ambrose J.A.
        • Bongu R.M.
        • et al.
        Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial.
        J Am Coll Cardiol. 1995; 26: 961-966
        • Considine R.V.
        • Sinha M.K.
        • Heiman M.L.
        • et al.
        Serum immunoreactive leptin concentrations in normal-weight and obese humans.
        N Engl J Med. 1996; 334: 292-295
        • Nyholm B.
        • Fisker S.
        • Lund S.
        • Moller N.
        • Schmitz O.
        Increased circulating leptin concentrations in insulin-resistant first-degree relatives of patients with non-insulin-dependent diabetes mellitus: relationship to body composition and insulin sensitivity but not to family history of non-insulin-dependent diabetes mellitus.
        Eur J Endocrinol. 1997; 136: 173-179
        • Bodary P.F.
        • Gu S.
        • Shen Y.
        • Hasty A.H.
        • Buckler J.M.
        • Eitzman D.T.
        Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice.
        Arterioscler Thromb Vasc Biol. 2005; 25: 119-122
        • Wallace A.M.
        • McMahon A.D.
        • Packard C.J.
        • et al.
        Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).
        Circulation. 2001; 104: 3052-3056
        • Hasty A.H.
        • Shimano H.
        • Osuga J.
        • Namatame I.
        • Takahashi A.
        • Yahagi N.
        Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor.
        J Biol Chem. 2001; 276: 37402-37408
        • Wolk R.
        • Berger P.
        • Lennon R.J.
        • Brilakis E.S.
        • Johnson B.D.
        • Somers V.K.
        Plasma leptin and prognosis in patients with established coronary atherosclerosis.
        JACC. 2004; 44: 1819-1824
        • Soderberg S.
        • Ahren B.
        • Jansson J.H.
        • et al.
        Leptin is associated with increased risk of myocardial infarction.
        J Intern Med. 1999; 246: 409-418
        • Taneli F.
        • Yegane S.
        • Ulman C.
        • et al.
        Increased serum leptin concentrations in patients with chronic stable angina pectoris and ST-elevated myocardial infarction.
        Angiology. 2006; 57: 267-272
        • Santos-Alvarez J.
        • Goberna R.
        • Sanchez M.V.
        Human leptin stimulates proliferation and activation of human circulating monocytes.
        Cell Immunol. 1999; 194: 6-11
        • Loffreda S.
        • Yang S.Q.
        • Lin H.Z.
        • et al.
        Leptin regulates proinflammatory immune responses.
        FASEB J. 1998; 12: 57-65
        • Sanchez M.V.
        • Martin-Romero C.
        • Santos-Alvarez J.
        • Goberna R.
        • Najib S.
        • Gonzalez-Yanes C.
        Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action.
        Clin Exp Immunol. 2003; 133: 11-19
        • Biasucci L.M.
        • Vitelli A.
        • Liuzzo G.
        • et al.
        Elevated levels of interleukin-6 in unstable angina.
        Circulation. 1996; 94: 874-877
        • Smith D.A.
        • Irving S.D.
        • Sheldon J.
        • Cole D.
        • Kaski J.C.
        Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina.
        Circulation. 2001; 104: 746-749
        • Alam S.E.
        • Nasser S.S.
        • Fernainy K.E.
        • Habib A.A.
        • Badr K.F.
        Cytokine imbalance in acute coronary syndrome.
        Curr Opin Pharmacol. 2004; 4: 166-170
        • Mourkarbel G.V.
        • Arnaout M.S.
        • Alam S.E.
        C-reactive protein is a marker for a complex culprit lesion anatomy in unstable angina.
        Clin Cardiol. 2001; 24: 506-510
        • Zairis M.N.
        • Papadaki O.A.
        • Manousakis S.J.
        • et al.
        C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina.
        Atherosclerosis. 2002; 164: 355-359
        • Pearson T.A.
        • Mensah G.A.
        • Alexander R.W.
        • et al.
        Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
        Circulation. 2003; 107: 499-511